LG Life Sciences won EPO patent for its SR-hGH formulation technology

Published: 2002-12-23 06:58:00

Updated: 2002-12-23 06:58:00

LG Life Sciences said on December 17 that it won a European Patent Office (EPO) for a novel formulation technology applied to a sustained-release human growth hormone (SR-hGH).

The company noted it filed the patent application for the sustained-release composition of drugs encapsulated in micr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK